Validation of antibiotic mode of action in whole bacterial cells is a key step for antibiotic drug discovery. In this study, one potential drug target, enoyl-acyl carrier protein reductase (FabI), an essential enzyme in the fatty acid biosynthesis pathway, was used to evaluate the feasibility of using a regulated antisense RNA interference approach to determine antibiotic mode of action. Antisense isogenic strains expressing antisense RNA to fabI were created using a tetracycline-regulated vector in Staphylococcus aureus. We demonstrated that down-regulation of FabI expression by induction of fabI antisense RNA induces a conditional lethal phenotype. In contrast, partial down-regulation gives a viable cell with a significant increase in sensitivity to FabI-specific inhibitors (i.e., a sensitized phenotype). More importantly, the mode of action for novel FabI inhibitors has been confirmed using this genetic approach in whole cell assay. These results indicate that controlled antisense technology provides a robust tool for defining and tracking the mode of action of novel antibacterial agents.
Introduction
The emergence of multi-drug resistance in bacterial pathogens, especially methicillin-resistant and vancomycin-resistant Staphylococcus aureus, has caused healthcare concern worldwide [1, 2] . Therefore, there is an urgent need to discover new antibiotics with novel mechanisms of action to combat these antibiotic-resistant pathogens. The availability of genomic sequences of bacterial pathogens and new techniques involving gene knockout technology enable the construction of large numbers of null mutants and evaluate essentiality for bacterial growth [3, 4] . However, mutations of essential genes are not recoverable for further evaluation of the potential targets or for validation of antibiotic mechanism of action in whole cells unless special conditions are achieved.
Conditional lethal mutants have been used successfully to identify and characterize genes essential for viability [5, 6] . Regulated gene expression approaches described for di¡erent bacterial systems [7, 8] were successfully used to evaluate drug targets and the mode of action of antibacterial compounds [9, 10] . However, construction of a regulated promoter-controlled strain in S. aureus is very time-consuming. Recently, DNA microarray and proteomic approaches have increasingly been used to elucidate the cellular responses of bacteria to antimicrobial compounds in attempts to identify patterns that could suggest the mode of action of novel antibacterial agents [11^14] . Antisense RNA technology has been used e¡ectively to down-regulate gene expression [15^18] . We and other investigators have developed a regulated antisense RNA strategy to identify and characterize essential genes in S. aureus [19, 20] . Our goal is to create a speci¢c antisense isogenic strain for any given drug target and use it to determine and track mode of action for potential inhibitors. To test the hypothesis, we chose an attractive target FabI, an enoyl-acyl carrier protein (ACP) reductase, which catalyzes the last step of the chain elongation process in the essential fatty acid biosynthesis pathway [21^23] . In this study, we provide a detailed evaluation of using the regulated antisense RNA interference technique to determine and/or con¢rm the mode of action of compounds directed to a speci¢c target that exhibit antibacterial activity. More importantly, we present data to validate the mechanism of action for novel FabI inhibitors.
Materials and methods

Bacterial strains and media
Escherichia coli DH10B was used as a host for recombinant plasmids. E. coli DH10B carrying plasmids pYH4, pYJ20013, pYJ20014, pYJ20015 was incubated at 37 ‡C in LB medium containing erythromycin (Erm; 300 Wg ml 31 ) for selection. S. aureus RN4220/tetA(M) was used as a host and grown at 37 ‡C in tryptic soy broth (TSB) containing chloramphenicol (10 Wg ml 31 ) and tetracycline (Tc, 1 Wg ml 31 ). S. aureus control strain RN4220/tetA/ pYH4 and antisense isogenic strains JSB20013, JSB20014, and JSB20015 were incubated at 37 ‡C in TBS containing erythromycin (5 Wg ml 31 , TSB-Erm) for selection.
Construction of S. aureus fabI antisense strains
The oligonucleotide primers fabIfor1 (5P-GGTTGG-CGCGCCGGGATTAGATATTCTATCCG-3P; 51 bp upstream of the start codon) and fabIrev1 (5P-GAGCCA-CAATTGTTAATGAG-3P; 389 bp downstream of the start codon of fabI), fabIfor2 (5P-GGTTGGCGCGCCA-TATGTCATCATGGGAATCG-3P; 24 bp downstream of the start codon of fabI) and fabIrev1, and fabIfor3 (5P-GGTTGGCGCGCCGTTCAAAGCGATGAA-GAGG-3P; 209 bp downstream of the start codon of fabI) and fabIrev2 (5P-GCGTGGAATCCGCTATCTACATG-3P; 14 bp upstream of the stop codon of fabI) were used to amplify three di¡erent fabI fragments from S. aureus RN4220 genomic DNA. The bold face sequence in the oligonucleotide primers is the AscI recognition sequence. The resulting DNA fragments were cloned into pYH4 DNA in an antisense orientation, resulting in constructions pYJ20013 (fabIfor1/fabIrev1), pYJ20014 (fabIfor2/fabIrev1), and pYJ20015 (fabIfor3/fabIrev2), respectively ( Fig. 1) . These recombinant plasmid DNAs were electro- porated into RN4220/tetA as described [24] and denoted JSB20013, JSB20014, JSB20015, respectively.
Growth curves of S. aureus fabI antisense strains
S. aureus cell growth curves were obtained using an automated microtiter plate format. S. aureus strains were incubated at 37 ‡C overnight in TSB with appropriate antibiotics. The cultures were diluted to V10 4 CFU ml 31 with TSB containing appropriate antibiotics and Tc at concentrations of 0, 10, 50, 100, 250, 500, 750, or 1000 ng ml 31 . The cell growth was monitored at 37 ‡C by measuring OD 600nm every 15 min with 1 min mixing before each reading.
Western blot assay
S. aureus strains were incubated in TSB with appropriate antibiotics, in the absence or presence of 500 ng ml 31 of inducer Tc at 37 ‡C overnight. Cell pellets from 1 ml of culture at OD 600nm of 1.0 were collected by centrifugation and washed once with 1 ml phosphate-bu¡ered saline (PBS) and resuspended in 1 ml of PBS. Lysostaphin (100 Wg ml 31 ) was used to lyse the cells [19] . Protein concentrations were determined by using Bio-Rad protein assay reagent. Equal amounts of protein samples were loaded onto a sodium dodecyl sulfate (SDS)^polyacrylamide gel electrophoresis gel and Western immunoblotting was performed as described [18] .
Northern blot analysis
S. aureus strains were grown in TSB with appropriate antibiotics to OD 600nm of V0.3 with and without Tc (500 ng ml 31 ), and total RNA was extracted by using a Qiagen RNAEasy mini protocol kit. 10 Wg of total RNA sample was separated by electrophoresis on a 1.2% agarose gel containing 1.8% formaldehyde gel and blotted onto a nylon membrane. The RNA was cross-linked to the membrane by UV irradiation. Blots were assayed as previously described [18] using a DIG-labelled fabI440 (5P-AGCTAACAAGAAGCCTTCACGTGAAGTTTCA-GAAAAGCGTCCGCGTAAGTC-3P) and fabI490 (5P-GACTTACGCGGACGCTTTTCTGAAACTTCACGTG-AAGGCTTCTTGTTAGCT-3P) speci¢cally hybridized with fabI antisense RNA and sense mRNA respectively.
2.6. S. aureus susceptibility assay S. aureus strains were grown in TSB with appropriate antibiotics at 37 ‡C overnight and were diluted to V10 5 CFU ml 31 as cultures for minimum inhibitory concentration (MIC) assays with a 96-well microtiter format. Serial dilutions of 40 standard compounds (kindly provided by Dr. L. Voelker at GlaxoSmithKline) were prepared in TSB-Erm in a ¢nal assay volume of 100 Wl. 50 Wl of 10 5 CFU ml 31 bacteria was added to the serially diluted antibiotics. The MIC was considered to be the concentration at which the antibiotic prevented turbidity in the well after incubation for 18 h at 37 ‡C.
Results and discussion
Construction of speci¢c antisense RNA isogenic strains
Regulated promoter approaches have been successfully used to con¢rm antibiotic mode of action in whole bacterial cells [9, 10] . However, to construct promoter-regulated strains especially in S. aureus is time-consuming. Therefore, we proposed to use an alternative regulated antisense RNA approach to down-regulate target gene expression and generate sensitized bacterial cells. To prove the concept, we chose a potential target FabI to construct regulated antisense strains in S. aureus as described in Section 2 (Fig. 1A) . Three di¡erent fabI antisense strains were constructed. To evaluate the requirement of FabI for cell viability by observing the consequences of titrating down its expression level, conditional phenotypes of fabI antisense isogenic strains were compared on TSA-Erm plates in the presence of the same concentration of antisense inducer (Tc) after overnight incubation. All S. aureus strains grew normally in the absence of Tc (Fig. 1B) . As a control, growth of S. aureus carrying empty vector pYH4 with and without the Tc induction phenotype was monitored and shown to be una¡ected. In contrast, growth defects (JSB20015) and lethal phenotypes (JSB20013 and JSB20014) were observed after induction of fabI antisense RNA.
Growth inhibition of strains JSB20013, JSB20014, JSB20015, and control strain RN4220/tetA(M)/pYH4 was also examined in a liquid medium containing various amounts of inducer, Tc. The results indicated that inhibition of bacterial cell growth was dependent not only on the extent of antisense induction but also on the location of the antisense fragment within the fabI gene. The control, RN4220/tetA(M)/pYH4, did not show signi¢cant di¡erence in growth (Fig. 2D) . However, cultures of JSB20013 ( Fig. 2A), JSB20014 (Fig. 2B) , and JSB20015 (Fig. 2C ) grew signi¢cantly more slowly in the presence of Tc ( v 250 ng ml 31 ). Furthermore, JSB20013 and JSB20014 showed similar growth characteristics with increased inducer concentrations and almost complete cessation of growth v 500 ng ml 31 of Tc. These results are consistent with previous observations on solid medium. Although FabI is essential for cell viability, JSB20015 was still able to grow during induction of antisense RNA. This result is consistent with previous ¢ndings that not all antisense RNAs are equally e¡ective in preventing gene expression [25, 26] .
Characterization of S. aureus fabI antisense strains
In order to demonstrate that the growth-de¢cient/lethal phenotypes were caused by speci¢c inhibition of target gene expression driven from the normal fabI chromosomal locus through induced antisense RNA, we characterized the production of transcripts of the fabI fragments in response to Tc induction and assessed the e¡ects of this induction on FabI gene expression.
Firstly, we analyzed RNA production from fabI antisense strains before and after induction. The results (Fig.  3A,B) show that JSB20013, JSB20014, and JSB20015 generated antisense fabI RNA even without Tc induction with a concomitant decrease in the level of fabI mRNA. These data indicate that this Tc-induced system is not tightly regulated. However, all three strains produced much more antisense fabI RNA products in response to Tc in- 3 . Northern blot analysis of fabI antisense RNA and mRNA during induction. Total RNA was puri¢ed and analyzed as described in Section 2. Blots were assayed (A) using DIG-labeled fabI440 speci¢cally hybridized with antisense RNA or (B) using DIG-labeled fabI490 specifically hybridized with mRNA. C: Control rRNA in the gel. duction, which resulted in undetectable levels of fabI sense mRNA. Secondly, we examined the e¡ect of these induced fabI antisense RNA segments on the levels of the endogenous fabI protein. Whole cell lysates of JSB20013, JSB20014, and JSB20015 without induction of antisense RNA reacted strongly with anti-FabI antisera (Fig. 4) . Following Tc induction, a signi¢cant decrease in FabI protein levels was observed. In contrast, reactivity of whole cell proteins against anti-FtsZ antiserum (an internal control against FtsZ, a cell division protein) was not a¡ected with or without Tc induction. Therefore, induced fabI antisense RNA was shown to speci¢cally inhibit endogenous FabI expression driven by the chromosomal fabI locus.
Determination of antibiotic mode of action
Titrating down the expression of a drug target gene by using regulated antisense RNA should cause a selective increase in sensitivity to an antibiotic directed to that protein. Therefore, the regulated antisense approach could be used to determine whether the cellular activity of an antibiotic functions through its proposed molecular target. To test this hypothesis, the FabI inhibitor triclosan, which is known to inhibit FabI and exhibit antibacterial activity against S. aureus [22] , and 39 other antimicrobial compounds with di¡erent mechanisms of action (such as DNA synthesis, transcription, translation, cell wall synthesis, membrane permeability, electron transport, lipid bio- Table 1 Antimicrobial activity (MIC values) of antimicrobial compounds against S. aureus with fabI antisense RNA expression Compound RN4220/tetA/pYH4 JSB20013 Tc = 0 Tc = 50 Tc = 500 Tc = 0 Tc = 50 Tc = 500 synthesis, and non-speci¢c mode of action inhibitors, such as detergent, ionophore, methyl viologen, and DNA intercalation) were assayed using S. aureus fabI antisense isogenic strains. A selective increase in susceptibility to its inhibitor would con¢rm the utility of the antisense approach.
DNA synthesis
As shown in Table 1 we found that downregulation of expression of FabI by induction of antisense RNA can signi¢cantly and selectively increase staphylococcal susceptibility to the FabI inhibitor triclosan. The MIC values were 0.125 Wg ml 31 in the absence of inducer, and decreased dramatically 64-fold to 0.0019 Wg ml 31 for JSB20013 (32-fold to 0.0039 Wg ml 31 for JSB20014, and 8-fold to 0.0156 Wg ml 31 for JSB20015, data not shown) in the presence of antisense induction. Moreover, during induction the extent of the MIC changes for triclosan against the three di¡erent fabI antisense strains correlated with their conditional phenotypes or apparent e¡ectiveness of the antisense RNA. In contrast, the MIC values for 39 independent control antimicrobial agents not targeting FabI were not changed signi¢cantly by induction of fabI antisense RNA (Table 1) . It is not known why the MIC values for paraquat, a methyl viologen and a non-speci¢c monoamine oxidase (MOA) inhibitor increased against both wild-type and antisense mutant strains during Tc induction.
Validation of mode of action for novel FabI inhibitors
The benzodiazepine derivative [27] and imidazole [28] were identi¢ed as inhibitors of S. aureus FabI by highthroughput screening of more than 300 000 compounds from the GlaxoSmithKline compound bank. Further optimization of these compounds by X-ray crystal structurebased design, described previously [27^30], has led to the identi¢cation of more potent inhibitors such as SB440002, SB416262, SB422805 and SB641197. Their enzymatic inhibitory activity (IC 50 ) and whole cell antimicrobial activity (MIC) have been demonstrated [27^30] . In this study, we further examined the mode of action for these novel synthetic inhibitors using the regulated antisense RNA interference approach. The fabI antisense strains showed a selective increase (4^16-fold) in sensitivity to the compounds which had previously been shown to inhibit FabI in vitro (Table 2 ). In contrast, no signi¢cant change of MIC was observed for SB lead compound SB416276, which has antibacterial activity but is known not to inhibit FabI (Table 2) . These results genetically con¢rmed that the mode of action of these novel antibacterial FabI inhibitors is indeed through interfering with the enzymatic activity of FabI in the essential fatty acid biosynthesis pathway. These results are consistent with recent ¢ndings that underexpression of FabI selectively inhibited acetate incorporation in S. aureus [23] . The respective MOAs of SB416276 (non-FabI) and SB416262 (FabI) were further con¢rmed by use of a FabI overexpressor and macromolecular biosynthesis (data not shown).
In conclusion, we validated the mechanism of action for four novel FabI-directed antimicrobials and demonstrated that the Tc-regulated antisense RNA system provides a robust tool for generating conditional lethal phenotypes in S. aureus and that this technique is useful in determining the essentiality of a known gene product for cell viability. Moreover, these techniques can be used to determine the mode of action of antibiotics and to con¢rm that the observed in vitro enzyme inhibition is the mechanism of bactericidal action against whole cells. The antisense MOA tool successfully distinguished the MOAs of two molecules from the same classô ne which killed via FabI (SB416262) and another (SB416276) which possessed an alternative and as yet unde¢ned MOA. 
